Welltower
US.WELL
236.17
-4.95
-2.05%
Welltower
236.17
-4.95
-2.05%
Collector offline (last heartbeat: 19137s ago)
· 2026-09-04 20:02
Pre-market
239.22
-0.79%
After-hours
235.55
-0.26%
Overnight
241.04
-0.03%
Revenue annual, last 8 years
Latest year +35.63% YoY
Margins
- Gross margin
- 39.18%
- Operating margin
- 3.33%
- Net margin
- 8.78%
Key ratios & quality
- PEG ratio
- 1.24
- Altman Z-Score
- 4.37
PEG uses trailing P/E against the 3-year net income growth rate (87.90%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.37, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.70B | 5.12B | 4.61B | 4.74B | 5.86B | 6.64B | 7.99B | 10.84B |
| Gross profit | 2.24B | 2.41B | 1.99B | 1.93B | 2.22B | 2.53B | 3.02B | 4.18B |
| Selling & admin expenses | 126.38M | 126.55M | 128.39M | 126.73M | 150.39M | 179.09M | 235.49M | 1.75B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.16B | 1.24B | 727.45M | 763.36M | 746.22M | 940.45M | 1.15B | 355.17M |
| Pretax profit | 423.49M | 542.89M | -31.55M | 170.75M | 173.06M | 350.05M | 524.44M | -480.03M |
| Tax | 8.67M | 2.96M | 9.97M | 8.71M | 7.25M | 6.36M | 2.70M | -7.12M |
| Net profit | 829.75M | 1.33B | 1.04B | 374.48M | 160.57M | 358.14M | 972.86M | 961.84M |
| Basic EPS | 2 | 3 | 2 | 1 | 0 | 1 | 2 | 1 |
| Diluted EPS | 2.02 | 3.05 | 2.33 | 0.78 | 0.30 | 0.66 | 1.57 | 1.39 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.42B | 2.55B | 2.69B | 3.18B | 3.35B | 3.54B |
| Gross profit | 926.20M | 1.00B | 1.05B | 1.20B | 1.25B | 1.37B |
| Selling & admin expenses | 63.76M | 64.18M | 63.12M | 1.56B | 67.47M | 67.49M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 378.58M | 443.33M | 476.99M | -943.73M | 558.42M | 564.44M |
| Pretax profit | 198.71M | 298.21M | 293.11M | -1.27B | 345.24M | 320.43M |
| Tax | -5.52M | 1.05M | 2.34M | -4.99M | 11.63M | -61.98M |
| Net profit | 257.27M | 304.62M | 282.19M | 117.77M | 752.32M | 462.98M |
| Basic EPS | 0 | 0 | 0 | 0 | 1 | 1 |
| Diluted EPS | 0.40 | 0.45 | 0.41 | 0.14 | 1.02 | 0.61 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.70B | 1.88B | 3.44B | 2.58B | 3.08B | 4.96B | 7.40B | 9.91B |
| Cash & ST investments | 215.38M | 284.92M | 1.55B | 269.27M | 631.68M | 1.99B | 3.51B | 5.03B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 30.34B | 33.38B | 32.48B | 34.91B | 37.89B | 44.01B | 51.04B | 67.30B |
| Total current liabilities | 2.18B | 2.10B | 622.75M | 1.34B | 1.17B | 1.10B | 1.37B | 1.86B |
| Short-term debt | 1.15B | 1.59B | -- | 324.94M | -- | -- | -- | -- |
| Long-term debt | 12.08B | 13.33B | 13.80B | 13.81B | 14.55B | 15.74B | 15.50B | 19.20B |
| Total liabilities | 14,331,427,000.00 | 16,398,247,000.00 | 15,258,580,000.00 | 15,912,452,000.00 | 16,499,237,000.00 | 17,640,439,000.00 | 18,471,722,000.00 | 24,100,108,000.00 |
| Total equity | 16.01B | 16.98B | 17.23B | 19.00B | 21.39B | 26.37B | 32.57B | 43.20B |
| Retained earnings | -4.70B | -4.87B | -5.02B | -5.72B | -6.71B | -7.63B | -8.22B | -9.16B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 7.19B | 8.29B | 11.09B | 9.91B | 10.00B | 7.86B |
| Cash & ST investments | 3.50B | 4.41B | 6.81B | 5.03B | 4.70B | 1.97B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 53.29B | 55.83B | 59.50B | 67.30B | 67.22B | 69.88B |
| Total current liabilities | 1.70B | 1.98B | 2.03B | 1.86B | 2.31B | 2.49B |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 15.72B | 15.97B | 16.85B | 19.20B | 17.93B | 17.73B |
| Total liabilities | 18,711,637,000.00 | 19,287,194,000.00 | 20,192,420,000.00 | 24,100,108,000.00 | 22,291,286,000.00 | 22,211,608,000.00 |
| Total equity | 34.58B | 36.55B | 39.31B | 43.20B | 44.93B | 47.66B |
| Retained earnings | -8.40B | -8.53B | -8.75B | -9.16B | -8.96B | -9.04B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.58B | 1.54B | 1.36B | 1.28B | 1.33B | 1.60B | 2.26B | 2.88B |
| Depreciation & amortization | 970.07M | 1.04B | 1.05B | 1.05B | 1.34B | 1.44B | 1.68B | 2.14B |
| Free cash flow | 1.58B | 1.52B | 1.35B | 1.26B | 1.30B | 1.55B | 2.20B | 2.85B |
| Dividends paid | -1.35B | -1.40B | -1.12B | -1.04B | -1.13B | -1.26B | -1.55B | -1.88B |
| Stock buybacks / issuance | 789.58M | 1.06B | 587.66M | 2.35B | 3.67B | 6.01B | 7.42B | 8.90B |
| Ending cash balance | 316.13M | 385.77M | 2.02B | 346.76M | 722.29M | 2.08B | 3.71B | 5.21B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 598.96M | 770.03M | 858.36M | 654.33M | 670.01M | 1.00B |
| Depreciation & amortization | 499.64M | 508.35M | 523.67M | 606.88M | 632.21M | 748.63M |
| Free cash flow | 587.44M | 761.38M | 852.21M | 646.85M | 661.56M | 994.78M |
| Dividends paid | -432.37M | -439.06M | -496.92M | -509.62M | -520.50M | -524.39M |
| Stock buybacks / issuance | 1.99B | 1.98B | 2.87B | 2.06B | 1.54B | 2.91B |
| Ending cash balance | 3.61B | 4.52B | 6.94B | 5.21B | 4.82B | 2.10B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE % | 5.49 | 8.37 | 6.21 | 2.00 | 0.74 | 1.49 | 3.32 | 2.53 |
| ROA % | 2.60 | 3.87 | 2.97 | 1.00 | 0.39 | 0.83 | 2.00 | 1.58 |
| ROIC % | 4.84 | 6.14 | 4.55 | 2.55 | 1.93 | 2.44 | 3.38 | 2.82 |
| 5-year avg ROE % | 5.31 | 6.20 | 6.17 | 5.09 | 4.56 | 3.76 | 2.75 | 2.02 |
| EBIT margin % | 20.34 | 21.54 | 10.53 | 14.03 | 12.16 | 14.79 | 13.99 | 1.61 |
| FCF / sales % | 33.74 | 29.82 | 29.37 | 26.67 | 22.48 | 23.94 | 27.99 | 26.70 |
| Current ratio | 0.78 | 0.89 | 5.52 | 1.93 | 2.63 | 4.51 | 5.40 | 5.34 |
| Quick ratio | 0.73 | 0.85 | 4.76 | 1.87 | 2.56 | 4.44 | 5.25 | 5.25 |
| Debt / assets | 95.57 | 99.02 | 89.01 | 83.22 | 73.73 | 63.45 | 52.44 | 50.75 |
| LT debt / equity | 87.32 | 88.81 | 89.01 | 81.38 | 73.73 | 63.45 | 52.44 | 50.75 |
| Interest coverage | 1.80 | 1.98 | 0.94 | 1.35 | 1.33 | 1.58 | 1.91 | 0.26 |
| Revenue CAGR (3Y) % | 6.74 | 6.26 | 2.18 | 0.27 | 4.23 | 12.20 | 18.59 | 22.69 |
| Net income CAGR (3Y) % | -3.07 | 4.57 | 23.25 | -25.26 | -51.43 | -29.70 | 41.47 | 87.90 |
| FCF CAGR (3Y) % | 4.68 | -2.13 | -1.75 | -7.29 | -5.14 | 4.81 | 20.51 | 29.93 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE % | 3.52 | 3.48 | 2.78 | 2.53 | 3.62 | 3.77 |
| ROA % | 2.21 | 2.23 | 1.77 | 1.58 | 2.34 | 2.47 |
| ROIC % | 3.30 | 3.29 | 2.78 | 2.82 | 3.19 | 3.63 |
| 5-year avg ROE % | -- | -- | -- | -- | -- | -- |
| EBIT margin % | 13.72 | 14.99 | 15.40 | 1.61 | 3.16 | 3.41 |
| FCF / sales % | 28.45 | 28.06 | 28.16 | 26.70 | 25.22 | 25.06 |
| Current ratio | 4.23 | 4.19 | 5.47 | 5.34 | 4.33 | 3.16 |
| Quick ratio | 4.16 | 4.13 | 5.40 | 5.25 | 4.28 | 3.10 |
| Debt / assets | 50.09 | 48.21 | 46.87 | 50.75 | 45.63 | 42.49 |
| LT debt / equity | 50.09 | 48.21 | 46.87 | 50.75 | 45.63 | 42.49 |
| Interest coverage | 2.02 | 2.36 | 2.49 | 0.26 | 0.52 | 0.58 |
| Revenue CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Seniors Housing Operating84.50%
Triple-net11.70%
Non-segment/Corporate2.50%
Outpatient Medical1.29%
Quote time 2026-09-04 20:02:18
For reference only, not investment advice.